These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 39250527)
1. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme. Kumar A; Shukla R J Biomater Sci Polym Ed; 2024 Sep; ():1-35. PubMed ID: 39250527 [TBL] [Abstract][Full Text] [Related]
2. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
3. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605 [TBL] [Abstract][Full Text] [Related]
4. Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions. Kumar N; Khurana B; Arora D Pharm Dev Technol; 2023 Dec; 28(10):1032-1047. PubMed ID: 37975846 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. Brar HK; Jose J; Wu Z; Sharma M Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678688 [TBL] [Abstract][Full Text] [Related]
7. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. Jnaidi R; Almeida AJ; Gonçalves LM Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610 [TBL] [Abstract][Full Text] [Related]
8. Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? van Woensel M; Wauthoz N; Rosière R; Amighi K; Mathieu V; Lefranc F; van Gool SW; de Vleeschouwer S Cancers (Basel); 2013 Aug; 5(3):1020-48. PubMed ID: 24202332 [TBL] [Abstract][Full Text] [Related]
9. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350 [TBL] [Abstract][Full Text] [Related]
10. Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma. Vikram ; Kumar S; Ali J; Baboota S Assay Drug Dev Technol; 2024; 22(2):73-85. PubMed ID: 38193798 [No Abstract] [Full Text] [Related]
11. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy. Khatri DK; Preeti K; Tonape S; Bhattacharjee S; Patel M; Shah S; Singh PK; Srivastava S; Gugulothu D; Vora L; Singh SB Curr Neuropharmacol; 2023; 21(3):493-516. PubMed ID: 35524671 [TBL] [Abstract][Full Text] [Related]
13. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review. Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997 [TBL] [Abstract][Full Text] [Related]
14. Contemporary strategies in glioblastoma therapy: Recent developments and innovations. Khan M; Nasim M; Feizy M; Parveen R; Gull A; Khan S; Ali J Neuroscience; 2024 Nov; 560():211-237. PubMed ID: 39368608 [TBL] [Abstract][Full Text] [Related]
15. Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease. Singh S; Shukla R AAPS PharmSciTech; 2023 Sep; 24(7):179. PubMed ID: 37658972 [TBL] [Abstract][Full Text] [Related]
16. Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics. Wang K; Zhang F; Wen C; Huang Z; Hu Z; Zhang Y; Hu F; Wen L Oncol Res; 2021; 29(5):351-363. PubMed ID: 37305160 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. Lim SH; Yee GT; Khang D Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170 [TBL] [Abstract][Full Text] [Related]
18. Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. Sabir F; Ismail R; Csoka I Drug Discov Today; 2020 Jan; 25(1):185-194. PubMed ID: 31629966 [TBL] [Abstract][Full Text] [Related]
19. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies. Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642 [TBL] [Abstract][Full Text] [Related]
20. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme. Bhaskaran M; Devegowda VG; Gupta VK; Shivachar A; Bhosale RR; Arunachalam M; Vaishnavi T ACS Chem Neurosci; 2020 Oct; 11(19):2962-2977. PubMed ID: 32945654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]